ASPIRIN FOR PRIMARY PREVENTION IN HIGH-RISK TYPE 2 DIABETES: INSIGHTS FROM THE ACCORD TRIAL
Therapeutic Area: ASCVD /CVD Risk Reduction Background: Aspirin is endorsed for preventing cardiovascular disease (CVD) in diabetes mellitus (DM) patients at elevated risk, balancing its benefits against the risk of bleeding; however, its efficacy for primary prevention in DM remains equivocal. This...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |